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In macrophages from inbred mice, the magnitude of the interferon (IFN) response to Newcastle disease virus
(NDV) infection is under genetic control of the If-i locus, which carries the allele for either high (h) or low (1)
IFN production. Here, we report that the activity of genes within the If-i locus is influenced by macrophage-
derived endogenous IFN. In addition to various other biological effects, we observed that endogenous IFN
specifically downregulated NDV-induced IFN and interleukin 6 production. Preculture of bone marrow-
derived macrophages (BMM) from BALB/c (If-i') mice in macrophage colony-stimulating factor plus
anti-WFN-j provoked a 30- to 50-fold increase in NDV-induced cytokine production compared with induced
control cultures in macrophage colony-stimulating factor alone, whereas only a 4- to 6-fold increase was
observed in anti-IFN-j-treated BMM from C57BL/6 (If-i) mice. This resulted in nearly complete abrogation
of the genetically determined difference in the response to NDV. The increase was specific for NDV and was
marked by strong additional activation of IFN-a genes. Studies using BMM from B6.C-H28c If-i congenic
mice gave results identical to those obtained with BALB/c BMM. Addition of 20 IU of recombinant IFN-a4 to
anti IFN-,-treated macrophages from B6.C-H28c mice 20 h prior to NDV infection strongly downregulated the
IFN-ax, IFN-1, and interleukin 6 responses. The genetic difference between macrophages from If ih and If-i'
mice was thus reestablished, since the same treatment caused only weak reduction of NDV-induced cytokine
gene expression in BMM from C57BL/6 mice. These data suggest that the If-I* and If-i' alleles harbor
IFN-inducible genes that, foliowing activation, specifically suppress subsequent cytokine gene expression in
response to NDV.
Virus-induced interferon (IFN) production in a host is
under genetic control. Studies using inbred strains of mice
have provided evidence for the existence of several loci that
specifically influence the amount of alpha/beta interferon
(IFN-a/W) produced following infection with one particular
virus (for reviews, see references 12 and 13). These loci,
named Ifloci, have high- and low-producer alleles which are
inducer specific in that they influence IFN production only
after contact with the corresponding inducer. The various If
loci are characterized by their quantitative effects on IFN
synthesis that lead to differences in IFN production between
3- and 30-fold, but their mode of action and gene products
are not known. The If-] locus, which specifically influences
IFN production by Newcastle disease virus (NDV), harbors
two alleles, If-P' and If-i', coding for high and low IFN
production, respectively. C57BL/6 mice harbor the high-
responder allele and BALB/c mice harbor the low-responder
allele, resulting in 10- to 20-fold differences in NDV-induced
circulating IFN levels. In vitro studies aimed at character-
izing the cell populations involved in IFN production re-
vealed that cultures of resident peritoneal macrophages from
C57BL/6 and BALB/c mice also expressed the correspond-
ing If-i allele when induced by NDV (15). Analysis of IFN
production in a variety of congenic lines generated by
repeated backcrossing of F1 progeny with C57BL/6 parental
mice led to the identification of the particular line B6.C-
H28c, carrying the If-i' allele and histocompatibility locus
H-28 from BALB/c on a C57BL/6 genetic background, since
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t Present address: Heinrich Pette-Institut, D-2000 Hamburg, Ger-
many.
NDV-induced IFN levels in these mice were similar to those
observed in BALB/c mice (14). In the present study, we used
cultures of bone marrow-derived macrophages (BMM) from
these mouse strains to study in more detail the regulatory
mechanisms of the If-1 locus on NDV-induced IFN produc-
tion. Our results indicate that the If-i locus also influences
interleukin 6 (IL-6) production in response to NDV and that
the If-I and If-i' alleles are differentially influenced by
macrophage-derived endogenous IFN.
MATERIALS AND METHODS
Mice. Male C57BL/6 and BALB/c mice were purchased
from the Zentralinstitut fur Versuchstierkunde, Hannover,
Germany. Male B6.C-H28c/By and additional C57BL/6 and
BALB/c mice were obtained from the Jackson Laboratories,
Bar Harbor, Maine. Throughout the experiments, 10- to
14-week-old animals were used.
Macrophage cultures. BMM were obtained as described
previously (23). The cells were cultured in RPMI 1640-10%
fetal calf serum (FCS) supplemented with 500 CFU of either
crude or purified mouse macrophage colony-stimulating fac-
tor (M-CSF) per ml prepared from L-cell conditioned me-
dium (LCM; kindly provided by E. R. Stanley; 42). When
indicated, 100 neutralizing units (NU) of either monoclonal
anti-mouse alpha interferon (anti-IFN-a) or monoclonal anti-
mouse beta interferon (anti-IFN-P) (kindly provided by Y.
Watanabe; 26) was added to the culture medium. Experi-
ments were routinely carried out on day 7 or 8, when
cultures consisted of more than 95% macrophages as ana-
lyzed by F4/80 antigen expression (22). LCM was continu-
ously monitored for the presence of antiviral activity. After
fivefold concentration by Amicon ultrafiltration, LCM was
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screened for induction of an antiviral state and of the 2'-5'
oligoadenylate synthetase (OASE) in mouse embryo fibro-
blasts. Controls included LCM to which 250 NU of mono-
clonal anti-IFN-a, anti-IFN-0, or both had been added 1 day
before. In no case, however, did we obtain evidence for the
presence of IFN activity in LCM.
Viruses. NDV strain Ulster (38) was isolated from infected
embryonated eggs as previously described (23). Virus titers
were determined in a standard hemagglutination assay using
chicken erythrocytes and are given as hemagglutination
units (HAU). The NDV preparation used in this study had a
titer of 3,600 HAU.
Herpes simplex virus type 1 (HSV) strain WAL was
prepared from infected RC-37 cells as previously described
(48).
Purification of monoclonal anti-IFN antibodies. Monoclonal
antibodies to mouse IFN-a and IFN-P were prepared from
culture supernatants of hybridoma lines 4EA1 and 7FD3,
respectively. The cell lines were a generous gift of Y.
Watanabe (26). Dense, confluent hybridoma cultures were
obtained after growth in RPMI 1640-10% FCS and incubated
for an additional 3 days in fresh RPMI 1640 without serum.
The medium was then recovered and concentrated 100-fold
following ammonium sulfate precipitation. The antibodies
were then purified by high-performance liquid chromatogra-
phy (Beckman System Gold) using rabbit anti-rat immuno-
globulin G coupled to Diasorb AC 1500 (Diagen). The
monoclonal antibodies eluted at pH 3. The neutralization
titers of the purified preparations from 4EA1 and 7FD3
supernatants were 1:8,000 against 4 IU of recombinant
IFN-a4 (rIFN-a4) and 1:24,000 against 4 IU of natural mouse
IFN-P, respectively.
Mouse rIFN-a4 was kindly provided by E. C. Zwarthoff
(46), and a preparation of natural mouse IFN-P (lot no.
82011; specific activity, 1.3 x 107 IU/mg) was purchased
from Stratech Scientific Ltd.
Induction and determination of IFN and IL-6 activities in
cultures of BMM. On day 7 of culture, BMM were detached
from petri dishes with a rubber policeman following incuba-
tion with ice-cold saline, reseeded into 24-well plates at a
density of 2.5 x 105 per well, and allowed to attach for 4 to
6 h. They were then incubated with NDV or HSV prepara-
tions for 1 h and refed, after removal of the inducer, with
fresh, prewarmed RPMI 1640-5% FCS. After overnight
incubation, supernatants were removed for IFN and IL-6
assays. For these experiments, purified mouse M-CSF (kind-
ly provided by E. R. Stanley; 42) was used in general, but
identical results were obtained with crude LCM as a source
of M-CSF. IFN and IFN neutralization tests to determine
the relative proportions of IFN-a and IFN-3 were performed
as previously described (23, 49). IL-6 activity was deter-
mined in a colorimetric proliferation assay (35) using sub-
clone B9.9 isolated from hybridoma cell line B13.29, kindly
provided by L. A. Aarden (1). One unit of IL-6 was defined
as giving half-maximal proliferation of B9.9 cells. Superna-
tants to be assayed for IL-6 were preincubated with excess
antibodies to mouse IFN-a/3 to neutralize the antiprolifera-
tive effect of mouse IFN on B9.9 cells.
DNA probes. Genomic DNA probes for mouse IFN-a1,
IFN-a2, and IFN-a4 and cDNA probes for IFN-P and IL-6
were kindly provided by E. Zwarthoff (50), Y. Kawade (21),
and J. van Snick (47), respectively. A 2.5-kb probe coding
for the F protein and part of the HN protein of NDV was
kindly provided by P. T. Emmerson (8, 9). For RNA blot
analysis, the probes were labeled with [a-32P]dCTP by
random priming (17).
Preparation of RNA and blot hybridization. Total cellular
RNA was extracted from mouse BMM with 4 M guanidinium
thiocyanate as described by Chirgwin et al. (10). Denatured
RNA was electrophoresed through agarose gels in the pres-
ence of formaldehyde (31) and transferred to nylon filters.
Hybridization was carried out as previously described (23).
For monitoring of identical amounts of cellular RNA per slot
on the filter membrane, probes were removed by shaking the
filters in a water bath at 70°C in 1.5 mM NaCl-0.01% sodium
dodecyl sulfate, followed by rehybridization to labeled p-ac-
tin cDNA (23).
Assay of OASE. IFN-induced, double-stranded RNA-de-
pendent OASE activity was determined as described previ-
ously (23). Briefly, the cells were lysed in a buffer containing
0.5% Nonidet P-40 and protein extracts were bound to
poly(IC) agarose (Pharmacia) and incubated with buffer
containing ATP (43). The 2'-5' oligo(A) produced was quan-
titated by a competition radioactivity binding assay (27).
Vesicular stomatitis virus (VSV) infection and virus titra-
tion. Macrophages were detached from petri dishes on day 7
of culture and plated on 35-mm-diameter petri dishes at a
concentration of 5 x 105 per dish. At 6 h later, the cells were
washed and infected with VSV (strain Indiana) in serum-free
medium by using a multiplicity of 2 PFU per cell. After
adsorption for 1 h at 37°C, the cell monolayer was washed
again to remove nonadsorbed virus particles and fresh,
prewarmed RPMI 1640 plus 5% FCS was added. To account
for residual input virus, an aliquot of the culture fluid was
removed 1 h later. At 14 h later, culture dishes were frozen
at -70°C to allow for approximately one replicative cycle of
VSV. Virus titrations were done by using a standard viral
plaque assay on a monkey kidney cell line as previously
described (29). The amount of input virus varied between 0.5
x 103 and 1.5 x 103 PFU per culture and was deduced from
the titers in the experimental groups.
RESULTS
Detection of endogenous IFN in cultures of BMM in the
presence of M-CSF. In cultures of BMM, endogenous IFN is
secreted constitutively in low amounts, and mostly its de-
tection has been possible only by indirect means, i.e.,
induction of IFN-induced OASE or establishment of an
antiviral state (23, 29, 36, 37). When we compared IFN
levels in culture supernatants from C57BL/6, BALB/c, and
B6.C-H28c macrophages, we observed significant differ-
ences in that BALB/c macrophages consistently secreted
between 12 and 54 IU of IFN whereas macrophages from the
two other strains produced low-to-undetectable amounts
(Table 1). As expected, the IFN levels increased with time of
culture and thus correlated with the number of mature
macrophages differentiating from myeloid precursor cells in
the presence of M-CSF. The highest titers were found on day
7, 1 day after the cultures were supplied with fresh medium.
The antiviral activity was completely neutralized by mono-
clonal antibodies to IFN-P. No differences were observed
between crude LCM and purified mouse M-CSF as medium
supplements (data not shown).
We also studied IFN gene expression at the RNA level by
Northern (RNA) blot analysis. As shown in Fig. 1, a
hybridization signal was observed for IFN-13 mRNA in
BALB/c BMM (lanes C) whereas no expression was detect-
able in BMM from C57BL/6 (lanes B) or B6.C-H28c con-
genic mice (data not shown). These results were in agree-
ment with IFN levels measured in the corresponding culture
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TABLE 1. Secretion of endogenous IFN in
M-CSF-cultured BMM
Rangec of IFN titers
Culture conditionsa (IU/ml) with the following
Day of macrophage donor:
cultureb
Anti-IFN-a Anti-IFN-P C57BU6 BALB/c B6.C-(NU) (NU) H28C
3 0 0-4 0
6 0 6-18 0-4
7 0-4 12-54 0-4
100 3 0 0-4 0
6 0 6-12 0
7 2-4 18-60 0-4
100 3 0 0 0
6 0 0 0
7 0 0 0
a BMM were cultured for 7 days in RPMI 1640 medium containing 10o FCS
and 500 CFU of purified mouse M-CSF per ml with or without antibodies to
IFN-a or IFN-3 as indicated.
b Day of removal of culture supernatant.
c From five different petri dishes.
IFN in macrophages is under genetic control. Similarly, we
also found endogenous IL-6 gene expression in M-CSF-
cultured BALB/c BMM (Fig. 1, lanes C). Interestingly,
however, no IFN-P and IL-6 mRNAs were visible in RNA
preparations from M-CSF-cultured macrophages kept in the
presence of anti-IFN-B (Fig. 1, lanes C). This finding sug-
gests that constitutive secretion of endogenous IFN-,B in
CONTROL
BALB/c macrophages is maintained by a positive feedback
mechanism.
Autocrine biological effects of endogenous IFN. (i) Cell
growth inhibition. Since IFN has antiproliferative effects on
hematopoietic cells, we compared the influence of endoge-
nous IFN on M-CSF-driven growth of macrophages from
C57BL/6, BALB/c, and congenic B6.C-H28c mice. Cultures
of bone marrow cells were set up in the presence of 500 CFU
of mouse M-CSF per ml with or without addition of 100 NU
of monoclonal anti-IFN-a or anti-IFN-P. The cell number
per petri dish on day 7 revealed a significantly reduced
growth rate in BALB/c BMM cultures (Table 2). Addition of
monoclonal anti-IFN-P, however, caused a pronounced in-
crease in BALB/c macrophage counts but had only little
influence on cell growth in C57BL/6 and B6.C-H28c BMM
cultures. The observed reduced growth rate of BALB/c
macrophages in M-CSF thus does not reflect a lower sensi-
tivity to M-CSF but rather is due to enhanced secretion of
endogenous IFN-P.
(ii) Induction of OASE activity. It has been shown that
endogenous IFN is responsible for elevated levels of OASE
in cultures of BMM (23, 29, 37). In view of the observed
differences in endogenous IFN levels, we also determined
the levels of OASE in BMM from all three of the mouse
strains under study. As can be seen additionally from Table
2, there was clear-cut induction of the enzyme in M-CSF-
cultured control macrophages from all of the mouse strains
compared with those treated with anti-IFN-P. Addition of
monoclonal anti-IFN-a had no effect. OASE activity was
also more elevated in macrophages from BALB/c mice than
in those from C57BL/6 and B6.C-H28c mice, probably also
NDV
IFN-a IFN-f IL- 6
Mousestrain: CCBB CCBB CCBB
anti-IFNP: + - + - +- +- + - +-
28 s - _ _










FIG. 1. Endogenous and NDV-induced cytokine gene expression in BMM from C57BL/6 and BALB/c mice. Bone marrow cells were
cultured in mouse M-CSF (500 CFU/ml) with or without addition of 100 NU of anti-IFN-,B. Total RNA was extracted from 7-day-old cultures
of pure BMM, either noninfected (control) or 8 h after infection with NDV (100 HAU/106 cells). Agarose gels with 10 ,ug of RNA per lane
were run, blotted onto nylon filters, and hybridized with the indicated cDNA probes. Filters hybridized to IFN-a probes were rehybridized
first to IL-6 cDNA and subsequently to 13-actin cDNA. Filters hybridized to the IFN-P probe were rehybridized to ,B-actin cDNA only. Mouse
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TABLE 2. Secretion of endogenous IFN by M-CSF-cultured BMM and its effect on cell growth, virus replication, and OASE activity
Mouse Culture conditionsa VSV replication Macrophage growth OASE activity
strain Anti-lFN-a Anti-IFN-p (PFU/culture)b (cell no., 106) oligo(A) mgf h-li]d
C57BL/6 - - 3.40 1.25 20,620
+ - 3.8 1.30 12,800
- + 6.18 1.35 1,500
BALB/c - - 3.08 0.76 98,000
+ - 3.60 0.90 92,000
- + 6.40 1.25 980
B6.C-H28C - - 3.60 1.20 NDe
+ - 3.71 1.25 ND
- + 6.3 1.35 ND
a BMM were cultured for 7 days in RPMI 1640 medium containing 10%o FCS and 500 CFU of purified mouse M-CSF per ml with or without 100 NU of
anti-IFN-a or anti-IFN-P as indicated.b VSV titers are given as logl0 values.
Cell numbers are means of six petri dishes. All assays were carried out on day 7 of culture.
d Enzyme activity was measured in cell extracts.
eND, not done.
because of the higher levels of endogenous IFN released
from BALB/c macrophages.
(iii) Induction of resistance to VSV infection. Cultures of
BMM set up in parallel were used to study the antiviral effect
of endogenous IFN on infection by VSV. In M-CSF-cultured
macrophages from all three mouse strains, VSV replication
was low, independently of the observed endogenous IFN
levels in the culture supernatants prior to infection (Table 2).
Anti-IFN-a treatment of macrophages caused a slight (five-
fold) rise in VSV titers, whereas in anti-IFN-p-treated cells
there was a 3-order-of-magnitude increase in virus yield.
Addition of 20 IU of rIFN-a4 to these cultures 18 h prior to
infection, however, induced a comparable antiviral state in
macrophages from all three mouse strains (data not shown),
indicating no differences in the sensitivities of BMM to the
antiviral effects of IFN.
(iv) No change in expression of macrophage maturation
markers. Since IFN possesses multiple immunomodulatory
effects, we investigated whether endogenous IFN in BMM
influenced M-CSF-driven differentiation by monitoring the
expression of the surface antigens Mac-1 and F4/80 (4, 40).
The Mac-1 glycoprotein complex (CD11b/CD18) is a mac-
rophage-granulocyte maturation marker which seems to be
involved in degranulation and cellular adhesion processes (3,
39). F4/80 is a specific marker for mouse mononuclear
phagocytes (25). Macrophages from 8-day-old cultures con-
taining 500 CFU ofM-CSF per ml with or without addition of
monoclonal anti-IFN-P were analyzed by fluorescence-acti-
vated cell sorter. In both groups, 88 to 96% of the cells
showed specific staining for either antigen. In addition, more
than 90% of all macrophages stained for the macrophage-
specific enzyme a-naphthyl-esterase and more than 95% of
the cells ingested heat-inactivated Saccharomyces cerevi-
siae particles (data not shown).
Specific regulation by endogenous IFN of NDV-induced
cytokine production. Production of IFN can be enhanced in
cell cultures by pretreatment of the cells with low doses of
IFN, a mechanism termed priming (18, 44). We were there-
fore interested to see whether endogenous IFN also exerted
a priming effect on subsequent NDV-induced IFN produc-
tion in BMM from C57BL/6 and BALB/c mice as high and
low responders, respectively. BMM were obtained by cul-
ture in the presence ofM-CSF plus neutralizing antibodies to
IFN-ca or IFN-P and induced on day 7 with NDV or HSV.
The results are depicted in Table 3. To our surprise, neutral-
ization of endogenous IFN by anti-IFN-P pretreatment did
not suppress but markedly enhanced subsequent IFN pro-
duction in response to NDV, whereas anti-IFN-oa had no
effect. The enhancing effect was much more pronounced in
macrophages from BALB/c mice, resulting in nearly com-
plete abrogation of the genetically determined differences in
IFN production between the two mouse strains. The effect
was also specific for NDV, since pretreatment of macro-
phages with anti-IFN-, had little influence on HSV-induced
IFN levels.
In addition, production of IL-6 in response to NDV
seemed to be controlled by similar host genes, since
C57BL/6 BMM again displayed the high-producer pheno-
type and endogenous IFN also differentially influenced IL-6
levels in BMM from high- and low-producer mouse strains
(Table 3).
TABLE 3. Virus-induced production of IFN and IL-6 in
M-CSF-cultured BMM: regulation of virus-induced
cytokine release by endogenous IFN
Preculture IFN concn (IU/mI) IL-6 concn (U/ml)
condition'
Inducer
IFN-t IFN-t C57BL/6 BALB/c C57BL/6 BALB/c
- - NDV 2,400 240 1,800 60
+ - NDV 2,700 300 1,500 60
- + NDV 16,200 8,400 3,600 2,500
+ + NDV 16,200 9,600 3,200 1,800
- - HSV 280 75 NDb ND
+ - HSV 210 90 ND ND
- + HSV 320 180 ND ND
+ + HSV 400 210 ND ND
a Macrophages were cultured for 7 days in purified mouse M-CSF alone
(500 CFU/ml) or M-CSF with or without 100 NU of either monoclonal
anti-IFN-a or monoclonal anti-IFN-j. The cells were then transferred to
24-well plates at 2.5 x 105 per well and induced with NDV (125 HAU/2.5 x
105 cells) or HSV at a multiplicity of 2. Culture supernatants were harvested
for cytokine assays 18 h later.
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Similar results were obtained when the amounts of NDV-
induced IFN-a, IFN-,, and IL-6 gene expression were
analyzed on the RNA level by Northern blot hybridization
(Fig. 1). This is in agreement with earlier results showing
that NDV-induced IFN production is regulated at the level
of transcription (24). RNA was extracted from macrophages
8 h after NDV infection, when maximal levels of IFN-a,
IFN-P, and IL-6 mRNAs had accumulated in macrophages
from all of the mouse strains tested, as analyzed in control
experiments (data not shown) and in previous studies (23,
24). As expected, steady-state levels of NDV-induced IFN
and IL-6 mRNAs were much higher in C57BL/6 BMM than
in BALB/c BMM when precultured in M-CSF alone. It is
also obvious that these cells almost exclusively expressed
IFN-, mRNA, whereas IFN-a mRNA was hardly detect-
able. Preculture in M-CSF plus anti-IFN-,B, however, not
only caused a strong increase in IFN-P mRNA levels in
response to NDV but, in particular, activated IFN-a gene
expression in BMM from both C57BL/6 and BALB/c mice.
Characterization of the corresponding culture supernatants
revealed a good correlation with mRNA levels: M-CSF-
cultured macrophages produced mainly IFN-P in response
to NDV, whereas a composition of about 50% IFN-a and
50% IFN-p was found in NDV-induced BMM precultured in
M-CSF plus anti-IFN-P (see Table 5). Analysis of NDV-
induced IL-6 mRNA levels in C57BL/6 and BALB/c macro-
phages revealed strong parallels to the regulation of IFN-P
gene expression. Again, there was a dramatic increase in
steady-state levels of IL-6 mRNA in BALB/c macrophages
precultured in the presence of anti-IFN-P, whereas in
C57BL/6 macrophages, IL-6 mRNA levels remained almost
unaffected.
Enhanced sensitivity to a particular biological effect of IFN
encoded by the If-i' locus. Since we had observed higher
levels of endogenous IFN in BMM from BALB/c mice, we
wanted to know whether the NDV-specific low-responder
phenotype of these cells resulted from dose-dependent
downregulation of cytokine gene expression by endogenous
IFN. To this end, we made use of the congenic line B6.C-
H28c. BMM from these mice produced very low or unde-
tectable amounts of endogenous IFN comparable to those of
BMM from the C57BL/6 parental strain (Table 1). Levels of
NDV-induced IFN, in contrast, were close to those of
BALB/c BMM (Table 4), since B6.C-H28c macrophages
express the If-II allele (15). However, preculture of B6.C-
H28C macrophages in M-CSF plus anti-IFN-1 resulted in
enhancement of the IFN response to NDV infection similar
to that observed for BALB/c. This indicates that the differ-
ences in endogenous IFN production are not responsible for
the low-responder phenotype of these cells. The data in
Table 4 also reveal that overnight exposure to 20 IU of
rIFN-a4 in the presence of anti-IFN-P also mediated strong
inhibition of NDV-induced IFN production in B6.C-H28c
and BALB/c macrophages, which both carry the If-i' allele,
whereas this inhibition was only marginal in C57BL/6 mac-
rophages expressing the If-lh allele. The inhibitory effect
mediated by exogenous or endogenous IFN was also specific
for NDV, since pretreatment of BMM with anti-IFN-,
caused little changes in the HSV-induced IFN response, and
addition of 20 IU rIFN-a4 prior to HSV infection even
resulted in slight enhancement of IFN titers (Table 4).
In addition, Northern blot analysis was performed in
parallel with RNAs from C57BL/6 and congenic B6.C-H28c
macrophages 8 h after NDV infection, and the results are
depicted in Fig. 2. Steady-state levels of IFN-a, IFN-1, and
IL-6 mRNAs were considerably enhanced by pretreatment
TABLE 4. Regulation by endogenous and exogenous IFN of
NDV- and HSV-induced IFN production in mouse macrophages
Preculture conditions' IFN titer (IU/ml) at 18 h postinduction with thefollowing macrophage donor:
Anti- Anti- Amt of C57BL/6 BALB/c B6.C-H28cAFNoti AFNt- rIFN-a____4__IFN-cs IFN-,B (IU) NDV HSV NDV HSV NDV HSV
- - 2,400 350 180 40 250 320
+ - 2,100 450 180 72 320 320
- + 16,200 320 9,600 96 10,800 360
- + 20 5,400 840 30 110 250 480
- + 200 4,800 260 <3 24 90 220
a Macrophages were cultured for 7 days in mouse M-CSF (500 CFU/ml)
with or without monoclonal anti-IFN-a or anti-IFN-,B (100 NU/ml). Macro-
phages were then transferred to 24-well plates at 2.5 x 105 per well, and 20 or
200 IU of rIFN-a4 was added to some of the cultures for 20 h in the presence
of anti-IFN-0. The cells were then induced by NDV (125 HAU/2.5 x 105 cells)
or HSV at a multiplicity of 2.
of the macrophages with anti-IFN-P (lanes 3) compared with
cells cultured in M-CSF alone (lanes 2). The enhancing effect
was much more pronounced for IFN-a than for IFN-, or
IL-6 mRNA. Upon exposure of macrophages to 20 IU of
rIFN-a4, we also observed strong inhibition of NDV-in-
duced cytokine expression on the RNA level (lanes 4), and
the inhibitory effect was most evident for IFN-a mRNA,
which became hardly detectable in these cells. In contrast,
there was little change in IFN-,B or IL-6 mRNA expression in
NDV-induced BMM from C57BL/6. The culture superna-
tants corresponding to these RNA preparations were ana-
lyzed in a neutralization assay using monoclonal anti-IFN-a
and anti-IFN-,. The results, summarized in Table 5, re-
vealed that the relative proportions of IFN-a and IFN-P
were in agreement with the observed steady-state mRNA
levels.
Influence of anti-IFN-I8 treatment of BMM on NDV repli-
cation. Partial primary transcription of the viral genome and
formation of double-stranded RNA intermediates after infec-
tion with single-stranded RNA viruses are considered one
mechanism that leads to efficient IFN induction by viruses
(16, 32, 33). We therefore investigated the possibility that
enhanced viral replication accounted for the high NDV-
specific IFN response in anti-IFN-,-treated macrophages.
No hemagglutination activity, however, was found in culture
supernatants from infected BMM, and similarly, no NDV
transcripts coding for the viral F protein were detected in
total RNA preparations from these cells (data not shown).
This indicates that nonpermissiveness of mouse macro-
phages to NDV infection is not due to an antiviral state
induced by endogenous IFN-13.
DISCUSSION
The present report deals with two major independent
findings: (i) macrophages from inbred mouse strains differ in
the capacity to produce endogenous IFN-1 during culture in
M-CSF, and (ii) the regulatory effect of the If-] gene locus on
NDV-induced cytokine release in macrophages is influenced
by endogenous IFN.
Secretion of low amounts of antiviral activity in cultures of
mouse BMM was initially described by Moore et al. (34), and
subsequently, indirect evidence was also obtained for the
secretion of endogenous IFN by macrophages in vivo (6, 20,
36). Our studies have documented significant differences in
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FIG. 2. Regulation by the If-] locus of NDV-induced cytokine gene expression in BMM. Total RNA was extracted from BMM and
analyzed by Northern blot hybridization as described in the legend to Fig. 1. Lanes: 1 and 5, noninfected BMM cultured in M-CSF alone;
2 and 6, NDV-infected BMM precultured in M-CSF alone; 3 and 7, NDV-infected BMM precultured in M-CSF plus anti-IFN-,; 4 and 8,
NDV-infected BMM precultured in M-CSF, anti-IFN-P, and 20 IU of rIFN-a4 for the last 20 h prior to NDV infection. Mouse strains: B,
C57BL/6; B.C, B6.C-H28c. Two exposure (Exp.) times of the same filters are presented to give a better impression of the differences in the
steady-state levels of individual cytokine mRNAs.
and C57BL/6 mice. The IFN was identified as IFN-,B, and
the differences between the two mouse strains were visible
on the RNA and protein levels, suggesting that host genes
regulate the amount of endogenous IFN gene expression.
Among the autocrine effects of endogenous IFN, we ob-
served pronounced growth inhibition in cultures of BALB/c
BMM compared with C57BL/6 BMM, and this was probably
due to the higher levels of endogenous IFN, since in the
presence of monoclonal anti-IFN-,, proliferation rates were
identical in the two cultures. It has also been reported that
BMM from BALB/c mice exhibit higher sensitivity to the
antiproliferative effect of exogenously added IFN-a/I (11),
and this higher sensitivity may further enhance the observed
growth-inhibitory effect in these cells. On the other hand, no
differences in IFN-mediated antiviral resistance to VSV was
detectable among BMM from C57BL/6, B6.C-H28c, and
BALB/c mice. This observation may be explained by the
fact that growth inhibition in general requires larger amounts
of IFN than does establishment of an antiviral state (45).
When we studied the regulation of cytokine release in
TABLE 5. Variation of NDV-induced levels of mouse IFN-a and
IFN-P in macrophages
11% % IFNCells IFN-a IFN-P titera
Peritoneal macrophages <10 >90 8-15
BMM cultured in:
M-CSF <10 >90 8-15
M-CSF + anti-IFN-P 40-50 50-60 1.8-2.5
M-CSF + anti-IFN-0 + rIFN-ot <10 >90 8-20
a If-lh/If-il (high- versus low-responder) ratio.
response to NDV, we found that BMM from BALB/c and
B6.C-H28C mice secreted considerably lower levels of IFN
and IL-6 than did BMM from C57BL/6 mice that were high
producers of both cytokines. Although coexpression of
IFN-, and IL-6-for which the term IFN-P2 had been used
previously-following induction by virus is a known phe-
nomenon (7, 30), these data additionally indicate that the If-l
locus regulates the production of both cytokines in response
to NDV. In addition, we made the striking observation that
endogenous IFN-P caused not priming but blocking of
IFN-a, IFN-P, and IL-6 gene expression after NDV infec-
tion of macrophages. The blocking effect was much more
pronounced in BMM from BALB/c and B6.C-H28c mice
than in those from C57BL/6 mice. This indicates that the
amount of blocking does not correlate with the level of
endogenous IFN secreted by these macrophages but rather
with their If-i' genotype, since BMM from congenic B6.C-
H28C mice also produced low or undetectable levels of
endogenous IFN-P, like cells from the C57BL/6 parental
strain. This hypothesis was further supported by the finding
that addition of identical amounts of mouse rIFN-a4 in the
presence of monoclonal anti-IFN-,B also exerted a suppres-
sive effect on subsequent NDV-induced cytokine produc-
tion, which was much more pronounced in BALB/c and
B6.C-H28c BMM with the If-i' genotype.
Taken together, there is evidence that the If-i locus
contains a gene(s) which is activated by IFN and that the two
alleles respond differently to endogenous IFN-P or exoge-
nous IFN-a. Considering specific inhibition of cytokine gene
expression as the only function attributable to these genes up
to now, we propose that genes within the If-i' allele display
higher activity when stimulated by IFN.
We can only speculate about the mechanism by which
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gene expression in macrophages. In view of the specificity
for NDV, the possibility that If-i-derived gene products in
general downregulate IFN and IL-6 production can be
excluded. They seem, rather, to interfere with NDV-specific
elements responsible for cytokine induction. In our study,
replication of the viral genome as assessed by F protein
cDNA could not be monitored in macrophages deprived of
endogenous IFN-P. It may be, however, that under these
conditions primary transcription of viral genes occurs, lead-
ing to formation of double-stranded RNA intermediates
which, in turn, induce IFN production. Activation by endog-
enous IFN of either If-i' or If-Ph would consequently result
in more- or less-pronounced inhibition of viral transcription
and double-stranded RNA formation, depending on the If-]
allele involved.
The physiological role of If-] remains to be elucidated.
Since the natural hosts of NDV are fowl, and mice are not
susceptible to this virus, it seems likely that the assumed
interference of mouse If-i gene products with NDV which
leads to downregulation of cytokine induction in host cells
does not represent its only function. Highly significant
individual variations in NDV-induced IFN titers have also
been observed in cultures of human peripheral blood leuko-
cytes (5), suggesting that regulatory gene loci similar to If-i
are also present in the human genome. This finding points to
a possible conservation of If-] during evolution and also
argues for additional biological functions of its gene prod-
ucts.
Concerning virus-specific action and inducibility by IFN,
some interesting parallels between If-i and the mouse Mx
gene emerge. This gene confers resistance to influenza virus
infection and is inducible by IFN-ot/, (for a review, see
reference 41). Its functional allele, Mx+, encodes a protein
which accumulates in the nucleus and specifically interferes
with influenza virus replication (28). Meanwhile, homologs
of the mouse Mx protein have also been identified in human
cells and their inducibility by IFN has been proven (2, 19). In
this respect, further studies concerning the alleles of If-i will
also be of significant interest for the characterization of one
or more new genes activated differentially by endogenous
IFN.
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